Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

Presentation TCT 2016

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner

November 01, 2016

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber

November 01, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Presenter: Marie-Claude Morice, Philip M. Urban

October 31, 2016

Presentation TCT 2016

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

Presenter: David W.M. Muller, Jonathan M. Hill, Philip M. Urban

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

News Features

精益求精：创新支架技术值得继续探索

Todd Neale

November 08, 2015

News Features

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

Todd Neale

November 08, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

Presentation TCT 2015

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent Versus Bare Metal Stents in Patients With Coronary Artery Disease at High Risk for Bleeding

Presenter: Cindy L. Grines, Philip M. Urban

October 14, 2015

Presentation TCT 2015

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent vs BMS in Patients With Coronary Artery Disease at High Risk for Bleeding

Presenter: Philip M. Urban

October 14, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

Presenter: Sigmund Silber, Philip M. Urban, Pil Hyung Lee

October 13, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Sigmund Silber, Philip M. Urban, Philippe Généreux

October 13, 2015

Advertisement

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Trial #3 - The Essentials of ... the LEADERS FREE trial

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

精益求精：创新支架技术值得继续探索

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent Versus Bare Metal Stents in Patients With Coronary Artery Disease at High Risk for Bleeding

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent vs BMS in Patients With Coronary Artery Disease at High Risk for Bleeding

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content